Advertisement

Psychopharmacology

, Volume 235, Issue 8, pp 2335–2347 | Cite as

The involvement of free fatty acid-GPR40/FFAR1 signaling in chronic social defeat stress-induced pain prolongation in C57BL/6J male mice

  • Fuka Aizawa
  • Kazuo Nakamoto
  • Shogo Tokuyama
Original Investigation

Abstract

Rationale

Depression and anxiety can cause the development of chronic pain. However, the mechanism of chronic pain induced by emotional dysfunction is still unknown. Previously, we demonstrated that the G protein-coupled receptor 40/free fatty acid receptor 1 (GPR40/FFAR1) signaling in the brain is related to regulation of both pain and emotion. In the present study, we proved that the role of GPR40/FFAR1 signaling in the development of chronic pain is induced by emotional dysfunction.

Results

Repeated social defeat (SD)-stressed mice showed the impairment of social interaction and anxiety behavior. These mice also caused pain prolongation after paw-incision comparison with non-SD mice. This pain prolongation was markedly continued by infusion of the GPR40/FFAR1 antagonist, GW1100 during SD stress but not non-SD stress. Although, infusion of the GW1100 during SD stress did not cause deterioration of the emotional behavior. Furthermore, GW1100-treated SD-mice showed strong tendency of emotional dysfunction after paw incision.

Conclusion

Our findings indicate that the dysfunction of fatty acids-GPR40/FFAR1 signaling in the brain underlying stress condition might be related to the development of chronic pain.

Keywords

Chronic pain Emotional dysfunction GPR40/FFAR1 Free fatty acid 

Notes

Funding information

Part of this experiment was supported by the Takeda Science foundation, by Grants-in-Aid and Special Coordination Funds from the Kobe Gakuin University Joint Research (A), and a Grant-in-Aid for Scientific Research (C) (15K10566) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Compliance with ethical standards

Ethical approval of the study protocol

This study was conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals adopted by the Japanese Pharmacological Society. The Ethical Committee for Animal Experimentation of the Kobe Gakuin University approved the experiments (approval number: 17-10, Kobe, Japan).

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

213_2018_4930_MOESM1_ESM.docx (22 kb)
ESM 1 (DOCX 22 kb)
213_2018_4930_MOESM2_ESM.pptx (341 kb)
ESM 2 (PPTX 341 kb)

References

  1. Aizawa F, Nishinaka T, Yamashita T, Nakamoto K, Kurihara T, Hirasawa A, Kasuya F, Miyata A, Tokuyama S (2016) GPR40/FFAR1 deficient mice increase noradrenaline levels in the brain and exhibit abnormal behavior. J Pharmacol Sci 132:249–254CrossRefPubMedGoogle Scholar
  2. Aizawa F, Ogaki Y, Kyoya N, Nishinaka T, Nakamoto K, Kurihara T, Hirasawa A, Miyata A, Tokuyama S (2017) The deletion of GPR40/FFAR1 signaling damages maternal care and emotional function in female mice. Biol Pharm Bull 40:1255–1259CrossRefPubMedGoogle Scholar
  3. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70:890–897CrossRefPubMedPubMedCentralGoogle Scholar
  4. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864–868CrossRefPubMedGoogle Scholar
  5. Brennan TJ, Vandermeulen EP, Gebhart GF (1996) Characterization of a rat model of incisional pain. Pain 64:493–501CrossRefPubMedGoogle Scholar
  6. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, Ellis C, Elshourbagy NA, Goetz AS, Minnick DT, Murdock PR, Sauls HR Jr, Shabon U, Spinage LD, Strum JC, Szekeres PG, Tan KB, Way JM, Ignar DM, Wilson S, Muir AI (2003) The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278:11303–11311CrossRefPubMedGoogle Scholar
  7. Chivers-Wilson KA (2006) Sexual assault and posttraumatic stress disorder: a review of the biological, psychological and sociological factors and treatments. Mcgill J Med 9:111–118Google Scholar
  8. Coderre TJ, Rollman GB (1984) Stress analgesia: effects of PCPA, yohimbine, and naloxone. Pharmacol Biochem Behav 21:681–686CrossRefPubMedGoogle Scholar
  9. Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K (2009) Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 25:1011–1019CrossRefPubMedPubMedCentralGoogle Scholar
  10. Crawley JN (2007) Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol 17:448–459CrossRefPubMedGoogle Scholar
  11. Galloway SK, Baker M, Giglio P, Chin S, Madan A, Malcolm R, Serber ER, Wedin S, Balliet W, Borckardt J (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 851276Google Scholar
  12. Hallahan B1, Hibbeln JR, Davis JM, Garland MR (2007) Omega-3 fatty acid supplementation in patients with recurrent self-harm: single-centre double-blind randomised controlled trial. Br J Psychiatry 190:118–122CrossRefPubMedGoogle Scholar
  13. Han C1, Pae CU (2015) Pain and depression: a neurobiological perspective of their relationship. Psychiatry Investig 12:1–8CrossRefPubMedPubMedCentralGoogle Scholar
  14. Harauma A, Moriguchi T (2011) Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by chronic mild stress. Lipids 46:409–416CrossRefPubMedGoogle Scholar
  15. Hashidate-Yoshida T, Harayama T, Hishikawa D, Morimoto R, Hamano F, Tokuoka SM, Eto M, Tamura-Nakano M, Yanobu-Takanashi R, Mukumoto Y, Kiyonari H, Okamura T, Kita Y, Shindou H, Shimizu T (2015) Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport. eLife 4Google Scholar
  16. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351:1213CrossRefPubMedGoogle Scholar
  17. Imig JD, Hammock BD (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 8:794–805CrossRefPubMedPubMedCentralGoogle Scholar
  18. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shinohara T, Hinuma S, Fujisawa Y, Fujino M (2003) Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature 422:173–176CrossRefPubMedGoogle Scholar
  19. Kiguchi N, Kobayashi Y, Saika F, Sakaguchi H, Maeda T, Kishioka S (2015) Peripheral interleukin-4 ameliorates inflammatory macrophage-dependent neuropathic pain. Pain 156:684–693CrossRefPubMedGoogle Scholar
  20. Ko GD, Nowacki NB, Arseneau L, Eitel M, Hum A (2010) Omega-3 fatty acids for neuropathic pain: case series. Clin J Pain 26:168–172CrossRefPubMedGoogle Scholar
  21. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391–404CrossRefPubMedGoogle Scholar
  22. Kudryavtseva NN, Bakshtanovskaya IV (1989) Experience of defeat increases the susceptibility to catatonic-like state in mice. Behav Process 20:139–149CrossRefGoogle Scholar
  23. Larrieu T, Hilal ML, De Smedt-Peyrusse V, Sans N, Layé S (2016) Nutritional omega-3 deficiency alters glucocorticoid receptor-signaling pathway and neuronal morphology in regionally distinct brain structures associated with emotional deficits. Neural Plast 8574830Google Scholar
  24. Larrieu T, Hilal ML, Fourrier C, De Smedt-Peyrusse V, Sans N, Capuron L, Layé S (2014) Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl Psychiatry 4:e437CrossRefPubMedPubMedCentralGoogle Scholar
  25. Li MJ, Liu LY, Chen L, Cai J, Wan Y, Xing GG (2016) Chronic stress exacerbates neuropathic pain via the integration of stress-affect related information with nociceptive information in the central nucleus of the amygdala. Pain 158:717–739CrossRefGoogle Scholar
  26. Marks DM, Shah MJ, Patkar AA, Masand PS, Park GY, Pae CU (2009) Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr Neuropharmacol 7:331–336CrossRefPubMedPubMedCentralGoogle Scholar
  27. Matsuda S, Peng H, Yoshimura H, Wen TC, Fukuda T, Sakanaka M (1996) Persistent c-fos expression in the brains of mice with chronic social stress. Neurosci Res 26:157–170CrossRefPubMedGoogle Scholar
  28. Miczek KA, Thompson ML, Shuster L (1982) Opioid-like analgesia in defeated mice. Science 215:1520–1522CrossRefPubMedGoogle Scholar
  29. Miczek KA, Thompson ML, Shuster L (1985) Naloxone injections into the periaqueductal grey area and arcuate nucleus block analgesia in defeated mice. Psychopharmacology 87:39–42CrossRefPubMedGoogle Scholar
  30. Miyamoto J, Hasegawa S, Kasubuchi M, Ichimura A, Nakajima A, Kimura I (2016) Nutritional signaling via free fatty acid receptors. Int J Mol Sci 17:450CrossRefPubMedPubMedCentralGoogle Scholar
  31. Nakamoto K, Aizawa F, Miyagi K, Yamashita T, Mankura M, Koyama Y, Kasuya F, Hirasawa A, Kurihara T, Miyata A, Tokuyama S (2017) Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice. PLoS One 12:e0180610CrossRefPubMedPubMedCentralGoogle Scholar
  32. Nakamoto K, Nishinaka T, Matsumoto K, Kasuya F, Mankura M, Koyama Y, Tokuyama S (2012) Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system. Brain Res 1432:74–83CrossRefPubMedGoogle Scholar
  33. Nakamoto K, Nishinaka T, Sato N, Aizawa F, Yamashita T, Mankura M, Koyama Y, Kasuya F, Tokuyama S (2015) The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system. Br J Pharmacol 172:1250–1262CrossRefPubMedPubMedCentralGoogle Scholar
  34. Nakamoto K, Nishinaka T, Sato N, Mankura M, Koyama Y, Kasuya F, Tokuyama S (2013) Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain. PLoS One 8:2–12CrossRefGoogle Scholar
  35. Nishinaka T, Yamashita T, Nakamoto K, Kasuya F, Tokuyama S (2014) Involvement of the long-chain fatty acid receptor GPR40 in depression-related behavior. J Pharmacol Sci 125:112–115CrossRefPubMedGoogle Scholar
  36. Pogatzki EM, Raja SN (2003) A mouse model of incisional pain. Anesthesiology 99:1023–1027CrossRefPubMedGoogle Scholar
  37. Prego-Dominguez J, Hadrya F, Takkouche B (2016) Polyunsaturated fatty acids and chronic pain: a systematic review and meta-analysis. Pain Physician 19:521–535PubMedGoogle Scholar
  38. Ramsden CE, Faurot KR, Zamora D, Palsson OS, MacIntosh BA, Gaylord S, Taha AY, Rapoport SI, Hibbeln JR, Davis JM, Mann JD (2015a) Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache. Pain 156:587–596CrossRefPubMedPubMedCentralGoogle Scholar
  39. Ramsden CE, Zamora D, Makriyannis A, Wood JT, Mann JD, Faurot KR, MacIntosh BA, Majchrzak-Hong SF, Gross JR, Courville AB, Davis JM, Hibbeln JR (2015b) Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress. J Pain 16:707–716CrossRefPubMedPubMedCentralGoogle Scholar
  40. Rivat C1, Becker C, Blugeot A, Zeau B, Mauborgne A, Pohl M, Benoliel JJ (2010) Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain 150:358–368CrossRefPubMedGoogle Scholar
  41. Sastry PS (1985) Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 24:69–176CrossRefPubMedGoogle Scholar
  42. Shively CA, Musselman DL, Willard SL (2009) Stress, depression, and coronary artery disease: modeling comorbidity in female primates. Neurosci Biobehav Rev 33:133–144CrossRefPubMedGoogle Scholar
  43. Suarez-Roca H, Leal L, Silva JA, Pinerua-Shuhaibar L, Quintero L (2008) Reduced GABA neurotransmission underlies hyperalgesia induced by repeated forced swimming stress. Behav Brain Res 189:159–169CrossRefPubMedGoogle Scholar
  44. Vadivelu N, Kai AM, Kodumudi G, Babayan K, Fontes M, Burg MM (2017) Pain and psychology—a reciprocal relationship. Ochsner J 17:173–180PubMedPubMedCentralGoogle Scholar
  45. Zhang E, Kim JJ, Shin N, Yin Y, Nan Y, Xu Y, Hong J, Hsu TM, Chung W, Ko Y, Lee W, Lim K, Kim DW, Lee SY (2017) High omega-3 polyunsaturated fatty acids in fat-1 mice reduce inflammatory pain. J Med Food 20:535–541CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Clinical Pharmacy, School of Pharmaceutical SciencesKobe Gakuin UniversityKobeJapan

Personalised recommendations